Dysfunction in the lymphatic system has been identified as a hidden driver of life-threatening heart valve disease in ...
Following a successful appeal of a December 2025 CRL, the FDA concluded that Outlook Therapeutics' existing data provided substantial evidence, eliminating the need for new clinical trials.
Sepsis, a life-threatening systemic inflammatory response triggered by infection, has long challenged clinicians with its persistently high mortality (up to 40-50% in septic shock). At the heart of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results